Vivo Bio Tech Ltd — Others, 04-08-2025: AGM/EGM

The company's shareholders have overwhelmingly approved a resolution to increase the Authorised Share Capital through a postal ballot. With 99.81% of polled votes in favour, this decision amends the Capital Clause of the company's Memorandum of Association. This strategic move provides the company with significant flexibility for future capital raising, potentially enabling equity issuances to fund operational expansion or other growth initiatives. This approval is a crucial step in preparing the company for future opportunities and strengthening its financial framework.